A joint fact sheet on the U.S.-U.K. Partnership for Global Development is available on the White House website. “Through the Partnership, we are working together to achieve better results by advancing economic growth; preventing conflict in fragile states; improving global health, particularly for girls and women; strengthening mutual accountability, transparency, and measurement of results; and mitigating the effects of climate change,” the fact sheet states, elaborating on joint efforts in each of these areas (3/14).
An antiretroviral (ARV) drug given to HIV-positive children “can boost the preventive power of a key malaria drug,” according to a study conducted in Uganda and presented last week at the 19th Conference on Retroviruses and Opportunistic Infections, ScienceNow reports. The researchers, led by clinicians Diane Havlir of the University of California, San Francisco (UCSF), and Moses Kamya of Makerere University College of Health Sciences, “compare[d] two different cocktails of anti-HIV drugs, only one of which contained protease inhibitors, in HIV-infected children who live in a malarial area of [Uganda]” and found “that one protease inhibitor indeed helped stave off malaria.”
“Ten months after the West African country [of Cote d’Ivoire] started to emerge from a presidential election crisis during which almost all hospitals and clinics had to shut down for a good six months because they had been vandalized, looted and occupied, the new government under President Alassane Ouattara is trying to make public health care a priority,” including implementing “[a] new national health regulation, which came into effect on Mar. 1, that offers free health services to pregnant women, children under five years and people suffering from malaria,” Inter Press Service reports. “But in a country recovering from 12 years of political instability since a military coup in December 1999 that was followed by 10 years of [former President Laurent] Gbagbo’s autocratic rule, rebuilding a crumbling public health care system takes time,” IPS writes, adding, “Hospitals have been suffering from lack of skilled staff, basic equipment and technology for years.”
PSI’s “Healthy Lives” blog presents global health-related excerpts of USAID Administrator Rajiv Shah’s annual letter that was published on March 9. Shah touches on programs to improve infant and child health; water, sanitation and hygiene; malaria prevention; HIV/AIDS care; and health care in several countries, including Afghanistan, Ghana and Ethiopia, according to the blog (3/9).
“While PEPFAR and the Global Health Initiative (GHI) have dominated the global health community’s attention over the past few years, the President’s Malaria Initiative (PMI) has largely flown under the radar,” Rachel Silverman, a research assistant for Center for Global Development’s (CGD) global health team, and Victoria Fan, a research fellow at CGD, write in this post in the CGD’s “Rethinking U.S. Foreign Assistance Blog.” They add, “But just this month, the PMI released the results of an external evaluation which confirms what we’ve long suspected: PMI is doing a remarkably good job and generating ‘value for money’ in U.S. global health efforts” (3/7).
“Global health programs now teeter on the edge of disaster,” Foreign Affairs writes in this feature article, adding, “The world economic crisis and the politics of debt reduction are threatening everything from malaria control and AIDS treatment to well-baby programs and health care worker training efforts.” The article provides a historical overview of global health programming and funding. “Like it or not, the burden of reducing suffering and increasing the health of the world’s poor now falls largely on the backs of the two Washingtons,” Foreign Affairs writes, referring to politicians in Washington and the Washington state-based Bill & Melinda Gates Foundation. The article concludes, “It would be a catastrophe were the ‘age of generosity’ to end so soon after it began, leaving millions without life-sparing medicines and tools they have come to rely upon” (Garrett, 5/6).
The Global Health Technologies Coalition (GHTC) — consisting of 40 global health research and advocacy organizations — on Tuesday held a congressional briefing to launch its third annual policy report, titled “Sustaining Progress: Creating U.S. policies to spur global health innovation,” GlobalPost’s “Global Pulse” blog reports (Donnelly, 2/28). The group is “warning deep cuts in the U.S. federal budget could reverse progress made on many diseases, including HIV/AIDS, tuberculosis and malaria,” VOA News writes (DeCapua, 2/28).
In this post in Malaria Free Future’s “Malaria Matters” blog, Bill Brieger, a professor in the health systems program of the Department of International Health at Johns Hopkins University, examines recent discoveries of fake malaria medications being sold in Tanzania. He writes, “All of this comes amid efforts of [the Affordable Medicines Facility malaria (AMFm)] to ensure that prequalified anti-malarial drugs reach the market (public and private) at prices people can afford. Cheap fake drugs threaten this effort.” He concludes, “Despite improved access to [artemisinin-combination therapies (ACTs)] and improved quality of front line medicine store outlets, Tanzania cannot let up on its pharmacovigilence” (2/27).
In this post in the Results for Development Institute’s “Center for Global Health R&D Policy Assessment” blog, Project Director Jean Arkedis and Program Associate Edith Han interview Megumi Gordon, deputy director for malaria at the Clinton Health Access Initiative (CHAI), “to take an exclusive look into the [Affordable Medicines Facility for Malaria (AMFm)] and its innovative mechanism to increase access to antimalarials.” Megumi discusses “AMFm’s current status, early lessons, and the latest in the ongoing — and sometimes contentious — debate about whether to subsidize [artemisinin-based combination therapies (ACTs)] in the private sector” (2/22).
USAID on Tuesday released the final report (.pdf) by an external evaluation team of the first five years (FY 2006-FY 2010) of the President’s Malaria Initiative (PMI), which is a major component of the Global Health Initiative (GHI), according to a USAID press release. “PMI leadership agrees with the overall findings and believes that the 10 main recommendations are both relevant and useful for program improvement,” the press release states, noting “[t]he evaluators gave the PMI high marks in effective leadership, good management and participatory processes” (2/21).